Cargando…

A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors

In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all o...

Descripción completa

Detalles Bibliográficos
Autores principales: Panaampon, Jutatip, Ngaosuwankul, Nathamon, Suptawiwat, Ornpreya, Noisumdaeng, Pirom, Sangsiriwut, Kantima, Siridechadilok, Bunpote, Lerdsamran, Hatairat, Auewarakul, Prasert, Pooruk, Phisanu, Puthavathana, Pilaipan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341361/
https://www.ncbi.nlm.nih.gov/pubmed/22563489
http://dx.doi.org/10.1371/journal.pone.0036318
_version_ 1782231533347667968
author Panaampon, Jutatip
Ngaosuwankul, Nathamon
Suptawiwat, Ornpreya
Noisumdaeng, Pirom
Sangsiriwut, Kantima
Siridechadilok, Bunpote
Lerdsamran, Hatairat
Auewarakul, Prasert
Pooruk, Phisanu
Puthavathana, Pilaipan
author_facet Panaampon, Jutatip
Ngaosuwankul, Nathamon
Suptawiwat, Ornpreya
Noisumdaeng, Pirom
Sangsiriwut, Kantima
Siridechadilok, Bunpote
Lerdsamran, Hatairat
Auewarakul, Prasert
Pooruk, Phisanu
Puthavathana, Pilaipan
author_sort Panaampon, Jutatip
collection PubMed
description In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all of these viruses as evaluated by hemagglutination-inhibition and microneutralization assays. In the presence of serum inhibitors, the infection by each virus was inhibited differently as measured by the amount of viral nucleoprotein produced in Madin-Darby canine kidney cells. The serum inhibitors inhibited seasonal influenza A(H3N2) virus the most, while the effect was less in seasonal influenza A(H1N1) and H1N1pdm viruses. The suppression by serum inhibitors could be reduced by heat inactivation or treatment with receptor destroying enzyme. In contrast, all H5N1 strains tested were resistant to serum inhibitors. To determine which structure (hemagglutinin (HA) and/or neuraminidase (NA)) on the virus particles that provided the resistance, reverse genetics (rg) was applied to construct chimeric recombinant viruses from A/Puerto Rico/8/1934(H1N1) (PR8) plasmid vectors. rgPR8-H5 HA and rgPR8-H5 HANA were resistant to serum inhibitors while rgPR8-H5 NA and PR8 A(H1N1) parental viruses were sensitive, suggesting that HA of HPAI H5N1 viruses bestowed viral resistance to serum inhibition. These results suggested that the ability to resist serum inhibition might enable the viremic H5N1 viruses to disseminate to distal end organs. The present study also analyzed for correlation between susceptibility to serum inhibitors and number of glycosylation sites present on the globular heads of HA and NA. H3N2 viruses, the subtype with highest susceptibility to serum inhibitors, harbored the highest number of glycosylation sites on the HA globular head. However, this positive correlation cannot be drawn for the other influenza subtypes.
format Online
Article
Text
id pubmed-3341361
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33413612012-05-04 A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors Panaampon, Jutatip Ngaosuwankul, Nathamon Suptawiwat, Ornpreya Noisumdaeng, Pirom Sangsiriwut, Kantima Siridechadilok, Bunpote Lerdsamran, Hatairat Auewarakul, Prasert Pooruk, Phisanu Puthavathana, Pilaipan PLoS One Research Article In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all of these viruses as evaluated by hemagglutination-inhibition and microneutralization assays. In the presence of serum inhibitors, the infection by each virus was inhibited differently as measured by the amount of viral nucleoprotein produced in Madin-Darby canine kidney cells. The serum inhibitors inhibited seasonal influenza A(H3N2) virus the most, while the effect was less in seasonal influenza A(H1N1) and H1N1pdm viruses. The suppression by serum inhibitors could be reduced by heat inactivation or treatment with receptor destroying enzyme. In contrast, all H5N1 strains tested were resistant to serum inhibitors. To determine which structure (hemagglutinin (HA) and/or neuraminidase (NA)) on the virus particles that provided the resistance, reverse genetics (rg) was applied to construct chimeric recombinant viruses from A/Puerto Rico/8/1934(H1N1) (PR8) plasmid vectors. rgPR8-H5 HA and rgPR8-H5 HANA were resistant to serum inhibitors while rgPR8-H5 NA and PR8 A(H1N1) parental viruses were sensitive, suggesting that HA of HPAI H5N1 viruses bestowed viral resistance to serum inhibition. These results suggested that the ability to resist serum inhibition might enable the viremic H5N1 viruses to disseminate to distal end organs. The present study also analyzed for correlation between susceptibility to serum inhibitors and number of glycosylation sites present on the globular heads of HA and NA. H3N2 viruses, the subtype with highest susceptibility to serum inhibitors, harbored the highest number of glycosylation sites on the HA globular head. However, this positive correlation cannot be drawn for the other influenza subtypes. Public Library of Science 2012-05-01 /pmc/articles/PMC3341361/ /pubmed/22563489 http://dx.doi.org/10.1371/journal.pone.0036318 Text en Panaampon et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Panaampon, Jutatip
Ngaosuwankul, Nathamon
Suptawiwat, Ornpreya
Noisumdaeng, Pirom
Sangsiriwut, Kantima
Siridechadilok, Bunpote
Lerdsamran, Hatairat
Auewarakul, Prasert
Pooruk, Phisanu
Puthavathana, Pilaipan
A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title_full A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title_fullStr A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title_full_unstemmed A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title_short A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors
title_sort novel pathogenic mechanism of highly pathogenic avian influenza h5n1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341361/
https://www.ncbi.nlm.nih.gov/pubmed/22563489
http://dx.doi.org/10.1371/journal.pone.0036318
work_keys_str_mv AT panaamponjutatip anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT ngaosuwankulnathamon anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT suptawiwatornpreya anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT noisumdaengpirom anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT sangsiriwutkantima anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT siridechadilokbunpote anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT lerdsamranhatairat anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT auewarakulprasert anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT poorukphisanu anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT puthavathanapilaipan anovelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT panaamponjutatip novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT ngaosuwankulnathamon novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT suptawiwatornpreya novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT noisumdaengpirom novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT sangsiriwutkantima novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT siridechadilokbunpote novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT lerdsamranhatairat novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT auewarakulprasert novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT poorukphisanu novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors
AT puthavathanapilaipan novelpathogenicmechanismofhighlypathogenicavianinfluenzah5n1virusesinvolveshemagglutininmediatedresistancetoseruminnateinhibitors